Works matching IS 13866346 AND DT 2023 AND VI 53 AND IP 2


Results: 11
    1
    2
    3

    Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real‐world data.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 116, doi. 10.1111/hepr.13852
    By:
    • Shimose, Shigeo;
    • Sugimoto, Rie;
    • Hiraoka, Atsushi;
    • Tanaka, Masatoshi;
    • Iwamoto, Hideki;
    • Tanaka, Yuki;
    • Tada, Fujimasa;
    • Ohama, Hideko;
    • Niizeki, Takashi;
    • Shirono, Tomotake;
    • Moriyama, Etsuko;
    • Noda, Yu;
    • Kamachi, Naoki;
    • Nakano, Masahito;
    • Kuromatsu, Ryoko;
    • Koga, Hironori;
    • Kawaguchi, Takumi
    Publication type:
    Article
    4
    5
    6

    Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 172, doi. 10.1111/hepr.13845
    By:
    • Tomonari, Tetsu;
    • Tani, Joji;
    • Ogawa, Chikara;
    • Deguchi, Akihiro;
    • Senoh, Tomonori;
    • Moriya, Akio;
    • Shibata, Hiroshi;
    • Fukuno, Hiroshi;
    • Tanaka, Hironori;
    • Tanaka, Takahiro;
    • Taniguchi, Tatsuya;
    • Sogabe, Masahiro;
    • Kawano, Yutaka;
    • Morishita, Akihiro;
    • Takaguchi, Koichi;
    • Miyamoto, Hiroshi;
    • Sato, Yasushi;
    • Masaki, Tsutomu;
    • Takayama, Tetsuji
    Publication type:
    Article
    7

    The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 104, doi. 10.1111/hepr.13843
    By:
    • Shimose, Shigeo;
    • Hiraoka, Atsushi;
    • Casadei‐Gardini, Andrea;
    • Tsutsumi, Tsubasa;
    • Nakano, Dan;
    • Iwamoto, Hideki;
    • Tada, Fujimasa;
    • Rimini, Margherita;
    • Tanaka, Masatoshi;
    • Torimura, Takuji;
    • Suga, Hideya;
    • Ohama, Hideko;
    • Burgio, Valentina;
    • Niizeki, Takashi;
    • Moriyama, Etsuko;
    • Suzuki, Hiroyuki;
    • Shirono, Tomotake;
    • Noda, Yu;
    • Kamachi, Naoki;
    • Nakano, Masahito
    Publication type:
    Article
    8
    9

    Issue Information.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 85, doi. 10.1111/hepr.13779
    Publication type:
    Article
    10
    11

    Clinically relevant model of oxaliplatin‐induced sinusoidal obstruction syndrome.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 145, doi. 10.1111/hepr.13842
    By:
    • Toda, Rei;
    • Seo, Satoru;
    • Uemoto, Yusuke;
    • Morino, Koshiro;
    • Nishino, Hiroto;
    • Nakamura, Naohiko;
    • Okuno, Masayuki;
    • Iguchi, Kohta;
    • Sato, Motohiko;
    • Nakamura, Kojiro;
    • Taura, Kojiro;
    • Nakagawa, Shunsaku;
    • Nakagawa, Takayuki;
    • Tsuruyama, Tatsuaki;
    • Manabe, Toshiaki;
    • Kawaguchi, Hiroaki;
    • Iwaisako, Keiko;
    • Ikegawa, Masaya;
    • Uemoto, Shinji;
    • Hatano, Etsuro
    Publication type:
    Article